DIFFERENT MODELS TO EVALUATE ANTIMICROBIAL AGENTS-A REVIEW
Abstract
Antimicrobial models have played a critical role in the history of modern drug development for microbial infections. Such antimicrobial models complement human investigations to study in detail pathogenic hypothesis and therapeutic strategies. To achieve this several new screening models have been produced. Various methods have been used for this purpose by using several microbes on different culture media. Such methods would help to provide new antimicrobial agents for the treatment of various microbial diseases of human. The present study therefore is focused on the review of such antimicrobial models.References
Role of Microorganism Infections in Chronic illnesses The CFIDS . The role of microorganism infections in chronic illnesses: Support for antibiotic regimens. By Garth Nicolson. www.cfids.org/archives/1999/1999-5-article06.asp
Ryan KJ; Ray CG (editors) (2004). Sherris Medical Microbiology (4th ed.). McGraw Hill. ISBN 0-8385-8529-9.
Glossary of Notifiable condition. Washington State Department of Health. Retrieved 2010-02-03.
This section incorporates public domain materials included in the text: Medical Microbiology Fourth Edition:Chapter 8 (1996) . Baron, Samuel MD. The University of Texas Medical Branch at Galveston.
Jan Hudzicki. Kirby-Bauer Disk Diffusion Susceptibility Test Protocol.American society for microbiology.2012.
Mohammadzadeh T., Sadjjadi SM, Habibi P, and Sarkari B. Evaluation of Anti-leishmanial Drugs on Leishmania promastigotes. Iran J Parasitol. 2012; 7(3): 43–47.
Arora, D.R., Arora, B. (2008) Text book of Microbiology, 3rd edition. CBSE publishers and distributors. New Delhi.
N.K. Jain. Pharmaceutical Microbiology. Revised and updated second edition. Delhi, Vallabh Prakashan, 2005.